• CCSC provides single cell measurement-based services for clinical trials and research.
• The focus is on pharmacodynamic assays.
• The flagship service is measurement of the level and activity of drug targets in specific cell types.
• We use immunofluorescence cytometry to define cell type and quantitatively measure epitope expression.

Founders:
James W. Jacobberger and Philip G. Woost

Officers:
James W Jacobberger, Ph.D. – President/Treasurer/CEO
Lorena S Jacobberger – Secretary
Howard Meyerson, M.D., Ph.D. – Quality Assurance Officer
Bruce Davis, M.D. – Quality Assurance Officer

Board:
James W Jacobberger, Ph.D.
Lorena S Jacobberger, B.A.
Brian Grimberg, Ph.D.
Keith Shults, B.S.

We formed this small company in late 2018 to provide cytometry support for research and clinical trials. It is based on a “full” service that Drs. Jacobberger and Woost built as members of the Case Comprehensive Cancer Center’s Cytometry & Microscopy Core, starting in 2012. This service provided full development and execution of cytometric assays, principally for clinical trials, but for any investigator without the laboratory physical resources, expertise, or labor to implement or develop an assay.  This service was founded on over 30 years experience in cytometry centered development and research within the Jacobberger research laboratory at Case Western Reserve University.